IPVV
IPVVUCIK 0002105274
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (FPS 10-K) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade IPVV commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
IPVVU (IPVV) prices 17.5M-unit SPAC IPO at $10.00/unit; $175M net proceeds to trust
6 material changes detected. Sign up free to read the summary.
IPVVU SPAC trims private placement, cuts cash outside trust to $1.25M
5 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 12, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statements of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | Six months ended June 30, 2026 |
|---|---|---|
| General and administrative expenses | 134,289 | 166,376 |
| Loss from operations | (134,289) | (166,376) |
| Other income: | ||
| Interest earned on cash and marketable securities held in Trust Account | 450,034 | 450,034 |
| Net income | 315,745 | 283,658 |
| Basic and diluted weighted average shares outstanding of Class A ordinary shares | 5,677,198 | 2,968,453 |
| Basic and diluted net income per ordinary share, Class A ordinary shares | 0.03 | 0.04 |
| Basic weighted average shares outstanding of Class B ordinary shares | 4,555,288 | 4,469,268 |
| Basic net income per ordinary share, Class B ordinary shares | 0.03 | 0.04 |
| Diluted weighted average shares outstanding of Class B ordinary shares (1) | 5,031,250 | 4,708,564 |
| Diluted net income per ordinary share, Class B ordinary shares | 0.03 | 0.04 |
Condensed Balance Sheets
| Description | June 30, 2026 (unaudited) | December 31, 2025 |
|---|---|---|
| Assets: | ||
| Current assets | ||
| Cash | 1,019,105 | 13,000 |
| Prepaid expenses | 21,175 | — |
| Short-term prepaid insurance | 62,500 | — |
| Total Current Assets | 1,102,780 | 13,000 |
| Deferred offering costs | — | 22,015 |
| Long-term prepaid insurance | 57,813 | — |
| Cash and marketable securities held in Trust Account | 201,700,034 | — |
| Total Assets | 202,860,627 | 35,015 |
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ (Deficit) Equity | ||
| Current liabilities | ||
| Accrued expenses | 21,521 | 5,487 |
| Accrued offering costs | — | 22,015 |
| Promissory note related party | — | 420 |
| Total current liabilities | 21,521 | 27,922 |
| Deferred underwriting fee | 8,575,000 | — |
| Total Liabilities | 8,596,521 | 27,922 |
| Commitments and Contingencies (Note 6) | ||
| Class A Ordinary Shares subject to possible redemption, $0.0001 par value; 20,125,000 and no shares at redemption value of $10.02 and $0 per share as of June 30, 2026 and December 31, 2025, respectively | 201,700,034 | — |
| Shareholders’ (Deficit) Equity | ||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of June 30, 2026 and December 31, 2025 | — | — |
| Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 540,000 and none issued and outstanding (excluding 20,125,000 and 0 shares subject to possible redemption) at June 30, 2026 and December 31, 2025, respectively | 54 | — |
| Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 5,031,250 shares issued and outstanding) at June 30, 2026 and December 31, 2025(1) | 503 | 503 |
| Additional paid-in capital | — | 24,497 |
| Accumulated deficit | (7,436,485) | (17,907) |
| Total Shareholders’ (Deficit) Equity | (7,435,928) | 7,093 |
| TOTAL LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY | 202,860,627 | 35,015 |
Condensed Statement of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 |
|---|---|
| Net income | 283,658 |
| Adjustments to reconcile net income to net cash used in operating activities: | |
| Interest earned on cash and marketable securities held in Trust Account | (450,034) |
| Payment of operation costs through promissory note | 18,375 |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | (21,175) |
| Accrued expenses | 16,034 |
| Short-term prepaid insurance | (62,500) |
| Long-term prepaid insurance | (57,813) |
| Net cash used in operating activities | (273,455) |
| Cash Flows from Investing Activities: | |
| Investment of cash into Trust Account | (201,250,000) |
| Net cash used in investing activities | (201,250,000) |
| Cash Flows from Financing Activities: | |
| Proceeds from sale of Units, net of underwriting discounts paid | 197,750,000 |
| Proceeds from sale of Private Placement Units | 5,400,000 |
| Proceeds from promissory note related party | 56,600 |
| Repayment of promissory note related party | (211,101) |
| Payment of offering costs | (465,939) |
| Net cash provided by financing activities | 202,529,560 |
| Net Change in Cash | 1,006,105 |
| Cash Beginning of period | 13,000 |
| Cash End of period | 1,019,105 |
| Non-Cash investing and financing activities: | |
| Offered costs included in accrued offering costs | 272,485 |
| Deferred offering costs paid through promissory note related party | 135,706 |
| Deferred underwriting fee payable | 8,575,000 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗